Psychotropic drugs in group homes: prevalence and relation to demographic/psychiatric variables. 1995

M G Aman, and G Sarphare, and W H Burrow
Massey University, Palmerston North, New Zealand.

All 1,101 clients residing in over 120 group homes of a residential services agency were surveyed on one date for presence of psychotropic medication. In all, 27% received one or more psychotropic drugs for behavioral or emotional disorders. Disorders and target behaviors listed for each drug group were examined and the relations between drug groups and diagnostic/demographic variables analyzed. In addition, logistic regression analyses were used to examine subject variable/drug relations further and the likelihood of receiving a specific class of medication given the presence of a subject variable. Certain physical and sensory handicaps were associated with less medication use. Generally speaking, the existence of DSM diagnoses (especially psychosis and mood disorder) and certain target behaviors were associated with greater medication use. In the main, medication use was consistent with known or presumptive indications for the respective drug groups, although unestablished applications were also observed.

UI MeSH Term Description Entries
D008297 Male Males
D008607 Intellectual Disability Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28) Disability, Intellectual,Idiocy,Mental Retardation,Retardation, Mental,Deficiency, Mental,Intellectual Development Disorder,Mental Deficiency,Mental Retardation, Psychosocial,Deficiencies, Mental,Development Disorder, Intellectual,Development Disorders, Intellectual,Disabilities, Intellectual,Disorder, Intellectual Development,Disorders, Intellectual Development,Intellectual Development Disorders,Intellectual Disabilities,Mental Deficiencies,Mental Retardations, Psychosocial,Psychosocial Mental Retardation,Psychosocial Mental Retardations,Retardation, Psychosocial Mental,Retardations, Psychosocial Mental
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009820 Ohio State bounded on the north by Michigan and Lake Erie, on the east by Ohio River and Pennsylvania, on the south by Ohio River, and on the west by Indiana.
D011618 Psychotic Disorders Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994) Psychoses,Psychosis, Brief Reactive,Schizoaffective Disorder,Schizophreniform Disorders,Psychosis,Brief Reactive Psychoses,Brief Reactive Psychosis,Disorder, Psychotic,Disorder, Schizoaffective,Disorder, Schizophreniform,Disorders, Psychotic,Disorders, Schizoaffective,Disorders, Schizophreniform,Psychoses, Brief Reactive,Psychotic Disorder,Reactive Psychoses, Brief,Reactive Psychosis, Brief,Schizoaffective Disorders,Schizophreniform Disorder
D011619 Psychotropic Drugs A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). Psychoactive Agent,Psychoactive Agents,Psychoactive Drug,Psychopharmaceutical,Psychopharmaceuticals,Psychotropic Drug,Psychoactive Drugs,Agent, Psychoactive,Agents, Psychoactive,Drug, Psychoactive,Drug, Psychotropic,Drugs, Psychoactive,Drugs, Psychotropic
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004363 Drug Utilization The utilization of drugs as reported in individual hospital studies, FDA studies, marketing, or consumption, etc. This includes drug stockpiling, and patient drug profiles. Utilization, Drug,Drug Utilizations,Utilizations, Drug
D005260 Female Females

Related Publications

M G Aman, and G Sarphare, and W H Burrow
September 2007, International journal of geriatric psychiatry,
M G Aman, and G Sarphare, and W H Burrow
August 1996, [Nihon koshu eisei zasshi] Japanese journal of public health,
M G Aman, and G Sarphare, and W H Burrow
May 1967, Diseases of the nervous system,
M G Aman, and G Sarphare, and W H Burrow
June 1996, Atencion primaria,
M G Aman, and G Sarphare, and W H Burrow
January 2004, Psychiatria polska,
M G Aman, and G Sarphare, and W H Burrow
January 1967, International journal of neurology,
M G Aman, and G Sarphare, and W H Burrow
March 1986, Psychosomatics,
M G Aman, and G Sarphare, and W H Burrow
March 2000, American family physician,
M G Aman, and G Sarphare, and W H Burrow
January 2005, Dialogues in clinical neuroscience,
Copied contents to your clipboard!